BIOVIE INC. (BIVI) Form 424B5 — Nov 4, 2026
BioVie filed Amendment No. 1 to its September 2026 prospectus supplement, cutting the maximum amount of Class A common stock it may sell through A.G.P./Alliance Global Partners under its ATM sales agreement from $6,464,341 to $1,225,000. The reduction appears driven by the one-third-of-public-float cap under General Instruction I.B.6 of Form S-3, since BioVie's public float is only about $17.9 million and it has already sold roughly $282,958 of stock under the program in the past 12 months.
Key figures
- Offering Price
- 1.73
- Shares Outstanding
- 8649835
- Reduced offering amount usd
- 1225000
- Original offering amount usd
- 6464341
- Float cap reference price usd
- 2.07
- Shares sold under program usd
- 282958
- Non affiliate shares outstanding
- 8649835
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.